2Speech & ABA Therapy Franchising

The vendor opportunity at 2Speech & ABA Therapy Franchising

2Speech & ABA Therapy Franchising operates a compact network of 13 units, split between 10 franchised locations and 3 company-owned sites. The system's average unit volume sits at $1,113,891, with a 5.0% royalty rate flowing back to the franchisor. For software vendors, the total addressable market is small—just 10 franchised doors—but the concentration of decision-making at headquarters simplifies the sales motion. The brand operates in the health-services segment and is independently owned, with no parent company on file. Its Texas headquarters houses the full buying center, meaning a single relationship can unlock the entire system.

Who controls software purchasing

The 2025 FDD lists five key executives in Item 1, and the group points to centralized control over technology decisions. Founders Nafisa Obi, Amber Lister, and Camila Trevino sit at the top of the organization, while Jessica Camp serves as Director of Franchise Operations and Shelby Nelson holds the Director of Clinical Quality role. In a system this size, the founders and the operations director are the most likely approvers for any new software investment. There is no separate CIO or CTO disclosed, so a vendor's pitch should speak to clinical-operational outcomes and franchisee compliance rather than pure IT architecture. The absence of a mapped operator footprint in our corpus further reinforces that purchasing power rests at HQ, not with individual franchisees.

Mandated and current tech stack

The only technology system explicitly mandated in the 2025 FDD is CentralReach, a practice-management platform built for ABA and therapy providers. CentralReach covers scheduling, billing, data collection, and clinical documentation, making it the operational backbone for the franchise. No other mandated or recommended vendors appear in the filing. For a software seller, this means the core EMR/PMS slot is occupied, but adjacent categories—such as HR, payroll, learning management, or parent-engagement tools—may be open if they can integrate with or complement CentralReach. The lack of additional named systems suggests either a lean tech stack or gaps that a vendor could fill.

Procurement, renewals, and timing

Procurement rules are opaque in the current disclosure. Item 8, which typically outlines whether franchisees must buy from designated suppliers or can source from approved alternatives, contains no extract. This silence leaves vendors without a clear picture of how rigid the purchasing path is. Similarly, the initial franchise term and Item 17 renewal conditions are not disclosed, making it impossible to estimate when contract windows might open or when franchisees face renewal-driven tech evaluations. Vendors should approach this account aware that the franchisor holds significant gatekeeping power, but the formal procurement guardrails remain undefined in the public filing.

How to read the 2Speech & ABA Therapy Franchising FDD

The full 2025 Franchise Disclosure Document is available below. Key sections for a software vendor include Item 1 for the leadership team, Item 11 for the mandated CentralReach disclosure, and Items 8 and 17—even when silent—to understand what the franchisor has chosen not to disclose. Because the system is small and founder-led, the FDD is the most reliable source of truth on who buys and what is already locked in. For a ranked target list that stacks this brand against other health-services franchises by tech-mandate strength and decision-maker accessibility, FranCloud can build that view.